Pregnancy immunogenetics: NK cell education in the womb?

Journal of Clinical Investigation

Volumn 120, Issue 11, 2010, Pages 3801-3804

  Parham, Peter ^a   Guethlein, Lisbeth A ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; FETAL ANTIGEN; HLA C ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL5; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DS1; NATURAL KILLER CELL RECEPTOR;

ANTIGEN RECOGNITION; CELL FUNCTION; EXTRACHROMOSOMAL INHERITANCE; GENE; GENE LOCUS; GENETIC RISK; HAPLOTYPE; HUMAN; IMMUNOGENETICS; INTRAUTERINE GROWTH RETARDATION; KIR GENE; NATURAL KILLER CELL; NIDATION; NOTE; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECURRENT ABORTION; TROPHOBLAST;

EMBRYO IMPLANTATION; FEMALE; FETUS; HLA-C ANTIGENS; HUMANS; IMMUNOGENETICS; KILLER CELLS, NATURAL; MALE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; RECEPTORS, KIR; UTERUS;

EID: 78049428708     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI44559     Document Type: Note

References (22)

1. Billingham RE, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature. 1953;172(4379):603-606.
2. Snell GD. Studies in histocompatibility. Science. 1981;213(4504):172-178.
3. Zinkernagel RM, Doherty PC. The discovery of MHC restriction. Immunol Today. 1997;18(1):14-17.
4. Thomas ED, Blume KG. Historical markers in the development of allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 1999;5(6):341-346.
5. Karre K. Natural killer cell recognition of missing self. Nat Immunol. 2008;9(5):477-480. (Pubitemid 351560515)
6. Moffett A, Loke C. Immunology of placentation in eutherian mammals. Nat Rev Immunol. 2006; 6(8):584-594.
7. Pijnenborg R, Brosens I, Romero R, eds. Placental Bed Disorders. Cambridge, United Kingdom: Cambridge University Press; 2010.
8. Hiby SE, et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med. 2004; 200(8):957-965.
9. Saito S, Takeda Y, Sakai M, Nakabayahi M, Hayakawa S. The incidence of pre-eclampsia among couples consisting of Japanese women and Caucasian men. J Reprod Immunol. 2006;70(1-2):93-98. (Pubitemid 43669092)
10. Hiby SE, et al. Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. J Clin Invest. 2010;120(11):4102-4110.
11. Tam LS, Gu J, Yu D. Pathogenesis of ankylosing spondylitis. Nat Rev Rheumatol. 2010;6(7):399-405.
12. Chung WH, Hung SI, Chen YT. Human leukocyte antigens and drug hypersensitivity. Curr Opin Allergy Clin Immunol. 2007;7(4):317-323. (Pubitemid 47052019)
13. Mandelboim O, et al. Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J Exp Med. 1996;184(3):913-922. (Pubitemid 26313549)
14. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol. 2005;5(3):201-214. (Pubitemid 40364822)
15. Moesta AK, Graef T, Abi-Rached L, Older Aguilar AM, Guethein LA, Parham P. Humans differ from other hominids in lacking an activating NK cell receptor that recognizes the C1 epitope of MHC class I. J Immunol. 2010;185(7):4233-4237.
16. Barclay AN, Hatherley D. The counterbalance theory for evolution and function of paired receptors. Immunity. 2008;29(5):675-678.
17. Anfossi N, et al. Human NK cell education by inhibitory receptors for MHC class I. Immunity. 2006; 25(2):331-342.
18. Fauriat C, Ivarsson MA, Ljunggren HG, Malmberg KJ, Michaelsson J. Education of human natural killer cells by activating killer cell immunoglobulin-like receptors. Blood. 2009;115(6):1166-1174.
19. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365(9461):785-799.
20. Single RM, et al. Global diversity and evidence for coevolution of KIR and HLA. Nat Genet. 2007; 39(9):1114-1119.
21. Gendzekhadze K, et al. Co-evolution of KIR2DL3 with HLA-C in a human population retaining minimal essential diversity of KIR and HLA class I ligands. Proc Natl Acad Sci U S A. 2009;106(44):18692-18697.
22. Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33(3):130-137.